Hypothalamus-liver talks: whispers in the language of metabolism
| dc.contributor.affiliation | Universidade de Santiago de Compostela. Centro de Investigación en Medicina Molecular e Enfermidades Crónicas (CiMUS) | |
| dc.contributor.author | Ferreira, Vitor | |
| dc.contributor.author | Fernández González, Iara | |
| dc.contributor.author | Vattathara, Jane Jose | |
| dc.contributor.author | Rodríguez Díaz, Amanda | |
| dc.contributor.author | Fernández Sanmartín, Paola | |
| dc.contributor.author | Diéguez González, Carlos | |
| dc.date.accessioned | 2026-04-22T07:07:15Z | |
| dc.date.available | 2026-04-22T07:07:15Z | |
| dc.date.issued | 2026-03-19 | |
| dc.description.abstract | Closely associated with the exponential increase of obesity and sedentary life, liver-related disorders are a major global health concern. Recent data suggest that the global prevalence of metabolic dysfunction-associated steatotic liver disease (MASLD) among adults is of 32% and 5.1% for alcohol-related liver disease, with hepatic disorders contributing to 4% of global mortality, accounting for approximately 2 million deaths annually. Over the past two decades, the hypothalamus has emerged as a central hub in regulating whole body metabolic and energy homeostasis. Nevertheless, the interactome between the hypothalamus and the liver in the progression of liver metabolic dysfunctions, as well as its potential as a therapeutic target, remains poorly understood. In this review, we provide a comprehensive overview of the current knowledge regarding the hypothalamus-liver crosstalk, with a particular emphasis on the mechanisms underlying it. We explore how signals transmitted by different hormones can modulate these interactions, shedding light on their functional implications for hepatic regulation and systemic homeostasis through central signals. | |
| dc.description.peerreviewed | SI | |
| dc.description.sponsorship | Open Access funding provided thanks to the CRUE-CSIC agreement with Springer Nature. The research group has received support from: Ministerio de Ciencia e Innovación co-funded by the FEDER Program of EU (CD: PID2023-149533NB-I00). CiMUS, and the researchers, were supported by the Xunta de Galicia (2020– 2023, ED431G/05; ED431C 2025/24). CIBER de Fisiopatología de la Obesidad y Nutrición is an initiative of ISCIII. VF is a recipient of a Juan de la Cierva contract (JDC2023-051969-I, AEI, Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. | |
| dc.identifier.doi | 10.1007/s11154-026-10031-y | |
| dc.identifier.essn | 1573-2606 | |
| dc.identifier.uri | https://hdl.handle.net/10347/46879 | |
| dc.journal.title | Reviews in Endocrine and Metabolic Disorders | |
| dc.language.iso | eng | |
| dc.page.final | 17 | |
| dc.page.initial | 1 | |
| dc.publisher | Springer | |
| dc.relation.projectID | info:eu-repo/grantAgreement/AEI/Plan Estatal de Investigación Científica y Técnica y de Innovación 2021-2023/PID2023-149533NB-I00/ES/EL SILENCIAMIENTO GENICO DE TPC1 GENERA UN FENOTIPO DE RESISTENCIA A LA OBESIDAD | |
| dc.relation.publisherversion | https://doi.org/10.1007/s11154-026-10031-y | |
| dc.rights | This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. | |
| dc.rights | Attribution 4.0 International | en |
| dc.rights.accessRights | open access | |
| dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | |
| dc.subject | Hypothalamus | |
| dc.subject | Liver disease | |
| dc.subject | Obesity | |
| dc.subject | Diabetes | |
| dc.subject | Insulin | |
| dc.subject | Amylin | |
| dc.subject | Glucagon | |
| dc.subject | GLP-1 | |
| dc.subject | FGF21 | |
| dc.title | Hypothalamus-liver talks: whispers in the language of metabolism | |
| dc.type | journal article | |
| dc.type.hasVersion | VoR | |
| dspace.entity.type | Publication | |
| relation.isAuthorOfPublication | 815a91a3-9556-464b-a328-c8587ae67d23 | |
| relation.isAuthorOfPublication | 5e85852a-86da-4c51-a990-34cc008a3ae7 | |
| relation.isAuthorOfPublication.latestForDiscovery | 815a91a3-9556-464b-a328-c8587ae67d23 |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- 2026_reviews_dieguez_hypothalamus.pdf
- Size:
- 1.48 MB
- Format:
- Adobe Portable Document Format